Original Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jan 28, 2009; 15(4): 431-440
Published online Jan 28, 2009. doi: 10.3748/wjg.15.431
Figure 5
Figure 5 Sensitivity of HepG2/mdr1 and HepG2/mdr1-siRNA to ADM. After transfected with pSUPER-shRNA/mdr1 vectors, the resistance of HepG2 cells to adiramycin and mytomycin decreased from 44.6-fold to 1.4-fold and from 138.1-fold to 1.14-fold.